The world’s first differentiated review of clinical studies examining the efficacy and safety of Cimicifuga racemosa (black cohosh) for menopausal complaints has been published in the international peer-reviewed journal, Evidence-Based Complementary and Alternative Medicine (eCAM). What sets this review apart from all other Cimicifuga reviews is that it corresponds with the characteristics of evidence-based Phytotherapy by differentiating according to extract, quality and indication. Accordingly, Oxford Levels of Evidence (LOE) and Grades of Recommendation (GR) have now been determined.
Remifemin has been given the top rating based on the highest level of evidence and highest grade of recommendation. See the attached PDF at the link below for full details!